Arbutus Biopharma Corporation ABUS Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by Arbutus Biopharma Corporation in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.
The official record: Arbutus Biopharma Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arbutus Biopharma Corporation's interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arbutus Biopharma Corporation's interest income?
- Arbutus Biopharma Corporation (ABUS) reported interest income of $815K in Q1 2026.
- How has Arbutus Biopharma Corporation's interest income changed year-over-year?
- Arbutus Biopharma Corporation's interest income decreased by 31.9% year-over-year, from $1.2M to $815K.
- What is the long-term trend for Arbutus Biopharma Corporation's interest income?
- Over 4 years (2021 to 2025), Arbutus Biopharma Corporation's interest income has grown at a 137.9% compound annual growth rate (CAGR), from $127K to $4.07M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.